ACN 090 987 250

15 November 2018

Company Announcements Office Australian Securities Exchange Limited Level 4, Exchange Centre

20 Bridge Street SYDNEY NSW 2000

By: e-lodgement

Dear Sir

RESULTS OF ANNUAL GENERAL MEETING

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of resolutions and the proxies received in respect of each resolution and are set out in the attached proxy summary.

All discretionary votes were in favour of the chair and were voted in favour of the resolutions.

Yours faithfully

STEPHEN CARTER

CHIEF EXECUTIVE OFFICER / MANAGING DIRECTOR

ASX Announcement No: 960

Level 1, Unit 12, 55 Howe Street, Osborne Park, WA 6017 Australia; PO Box 1719, Osborne Park BC, WA 6916 Australia

Telephone: + 61 8 6142 5555 Facsimile: +61 8 9443-8858

(E)info@sudapharma.com (W)www.sudapharma.com

SUDA PHARMACEUTICALS LIMITED

ACN: 090 987 250

Meeting Date: Thursday, 15 November 2018 Meeting Time:10.30 AM WST

Resolution

1 - ADOPTION OF THE REMUNERATION REPORT (NON-BINDING)

2 - RE-ELECTION OF DIRECTOR: MR STEPHEN CARTER 3 - RE-ELECTION OF NON-EXECUTIVE DIRECTOR: MR DAVID PHILLIPS 4 - RATIFICATION OF PRIOR ISSUE OF ORDINARY SHARES AND ATTACHING LISTED OPTIONS UNDER APLACEMENT

Manner in which the securityholder directed the proxy vote (as at proxy close):

For

352,087,621 363,251,223 527,352,243

514,341,397

Against

Proxy's Discretion1

166,366,170 138,995,469 13,741,480

20,695,870

251,108,055 251,465,847 251,465,847

Note 1: All discretionary votes were in favour of the chair and were voted in favour of the resolution

*Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item.

Advanced Share Registry Limited - Onsite Meeting System

Abstain

4,431,893 39,154,531

Manner in which votes were cast in person or by proxy on a poll(where applicable):

For

Against

The motion was passed on a show of hands.

Abstain

The motion was passed on a show of hands.

The motion was passed on a show of hands.

The motion was passed on a show of hands.

Page: 1

Attachments

Disclaimer

Suda Pharmaceuticals Ltd. published this content on 15 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 15 November 2018 05:23:05 UTC